SCHEMBL15626605

SCHEMBL15626605

Cc1ccc2[nH]c(-c3ccc(F)nc3)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.50
▸ RAB9A P51151 5/20 0.50
▸ PKM P14618 2/20 0.50
▸ KDM4E B2RXH2 5/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ HPGD P15428 3/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ NPBWR1 P48145 1/20 0.44
▸ MAPT P10636 3/20 0.43
▸ POLB P06746 1/20 0.43
▸ ALOX5 P09917 1/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ MMP2 P08253 1/20 0.42
▸ MMP9 P14780 1/20 0.42
▸ MMP8 P22894 1/20 0.42
▸ MMP13 P45452 1/20 0.42
▸ HPSE Q9Y251 1/20 0.41
▸ MITF O75030 1/20 0.41
▸ OPRM1 P35372 1/20 0.41
▸ OPRD1 P41143 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18365245 0.85 NPC1 (0.68) NPC1RAB9APKMKDM4EALDH1A1
SCHEMBL14494924 0.83 NPC1 (0.60) NPC1RAB9APKMKDM4EALDH1A1
SCHEMBL1687838 0.83 NPC1 (0.58) NPC1RAB9APKMKDM4EALDH1A1
SCHEMBL7574964 0.81 NPC1 (0.58) NPC1RAB9APKMKDM4EALDH1A1
SCHEMBL14128245 0.81 ALDH1A1 (0.60) NPC1RAB9APKMKDM4EALDH1A1
SCHEMBL4559600 0.81 NPBWR1 (0.55) NPBWR1
SCHEMBL10147166 0.80 NPC1 (0.42) NPC1RAB9APKMKDM4EALDH1A1
SCHEMBL12402878 0.79 NPC1 (0.68) NPC1RAB9APKMKDM4EALDH1A1
SCHEMBL14128551 0.78 CYP11B1 (0.65) NPC1RAB9APKMKDM4EALDH1A1
SCHEMBL1171203 0.78 NPC1 (0.51) NPC1RAB9APKMKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140088124-A1 IMIDAZOLE DERIVATIVES INTERVET INC. 2014-03-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088124-A1 IMIDAZOLE DERIVATIVES DGAT1, DGAT2, SOAT1 NPC1 30/4885RAB9A 1742/4885PKM 2576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback